News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Conference News EuroPCR 2017 My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not Shelley Wood June 02, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Daily News La Localización de la EAC Puede Influir en la Necesidad de Recibir Tratamiento Antiplaquetario Prolongado Post-PCI Caitlin E. Cox August 24, 2015
News Daily News CAD Location May Influence Need for Prolonged DAPT Post-PCI Caitlin E. Cox August 24, 2015
News Daily News Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI Yael L. Maxwell January 12, 2015